$75.10
+0.25 (+0.33%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+47.02%
1Y
+202.21%
YTD
+79.71%
Open$74.97
Previous Close$74.85
Day High$76.20
Day Low$73.51
52W High$77.00
52W Low$23.65
Volume—
Avg Volume831.5K
Market Cap6.60B
P/E Ratio—
EPS$-2.34
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$47.74
Above
SMA 200
$36.07
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-52.1% upside
Current
$75.10
$75.10
Target
$35.94
$35.94
$23.54
$35.94 avg
$41.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.60M | 3.43M | 1.61B |
| Net Income | -183,078,981 | -239,151,834 | -285,460,132 |
| Profit Margin | -3,985.0% | -7,343.0% | -17.7% |
| EBITDA | -215,306,367 | -328,687,347 | -344,556,820 |
| Free Cash Flow | — | — | -296,727,069 |
| Rev Growth | +176.6% | -52.1% | +15.2% |
| Debt/Equity | 0.00 | — | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |